What is SAVIS?
SAVIS is a distinguished project consulting firm boasting over three decades of specialized GMP expertise. The company delivers innovative engineering, validation, regulatory, and IT solutions tailored for the healthcare industry. Its entirely US-based team provides critical support to biotech, pharmaceutical, medical device, aeronautical, chemical, and food and beverage sectors, enabling clients to enhance their patient service capabilities. SAVIS is committed to delivering compliant solutions through robust management, engineering, and automation, ensuring both efficient project execution and strict adherence to regulatory standards. The firm's reputation for high-quality project support is further solidified by a substantial portion of its business originating from client referrals.
How much funding has SAVIS raised?
SAVIS has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in SAVIS
PPP
Public-Private Partnership
What's next for SAVIS?
The recent strategic investment, contextualized within SAVIS's large-scale late-stage funding, suggests a phase of accelerated growth and market expansion. This capital infusion is likely to empower SAVIS to further enhance its service offerings, potentially invest in new technological capabilities, and broaden its reach within its core sectors. The company's deep-rooted expertise in GMP and regulatory compliance positions it favorably to capitalize on evolving industry demands and to continue its trajectory as a trusted partner for complex project delivery in highly regulated environments.
See full SAVIS company page
